Synergistic effects of anti-CmeA and anti-CmeB peptide nucleic acids on sensitizing Campylobacter jejuni to antibiotics. Antimicrob Agents Chemother;57:4575


The CmeABC efflux pump in Campylobacter jejuni confers resistance to structurally divergent antimicrobials, and inhibition of CmeABC represents a promising strategy to control antibiotic-resistant Campylobacter. Antisense peptide nucleic acids (PNAs) targeting the three components of CmeABCwere evaluated for inhibition of CmeABC expression. The result revealed a synergis-tic effect of the PNAs targeting CmeA and CmeB on sensitizing C. jejuni to antibiotics. This finding further demonstrates the feasibility of using PNAs to potentiate antibiotics against antibiotic-resistant Campylobacter. Campylobacter jejuni is a major food-borne pathogen account-ing for 400 to 500 million cases of diarrhea each year world-wide (1). This organism is increasingly resistant to clinically important antibiotics, particularly fluoroquinolone (FQ) antimi-crobials (2). The CmeABC efflux pump in Campylobacter confers resistance to a broad range of antimicrobials and toxic com-pounds (3). In addition, this efflux pump functions synergistically with othermechanisms (e.g., spontaneousmutations in antibiotic targets) inmediating high-level resistance to antibiotics (3). Cme-ABC is also important for bile resistance and is essential for Cam-pylobacter colonization in the intestinal tract of animal hosts (4)

Similar works

Full text

oaioai:CiteSeerX.psu:10.1...Last time updated on 11/1/2017

This paper was published in CiteSeerX.

Having an issue?

Is data on this page outdated, violates copyrights or anything else? Report the problem now and we will take corresponding actions after reviewing your request.